View of Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis

Return to Article Details Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis Download Download PDF

Cited by

	All	Since 2021
Citations	6303	6083
h-index	28	28
i10-index	156	154

0

2500

1250

625

1875

20152016201720182019202020212022202320242025202619 18 22 28 43 57 101 291 334 567 2210 2479